TrialTherapeutic advances in respiratory disease

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT.

José M Marín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.